CN100528222C - 共聚物-1在制备治疗多发性硬化症的口服固体药物中的用途 - Google Patents
共聚物-1在制备治疗多发性硬化症的口服固体药物中的用途 Download PDFInfo
- Publication number
- CN100528222C CN100528222C CNB988031221A CN98803122A CN100528222C CN 100528222 C CN100528222 C CN 100528222C CN B988031221 A CNB988031221 A CN B988031221A CN 98803122 A CN98803122 A CN 98803122A CN 100528222 C CN100528222 C CN 100528222C
- Authority
- CN
- China
- Prior art keywords
- copolymer
- fed
- eae
- cells
- multiple sclerosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Treatments Of Macromolecular Shaped Articles (AREA)
- Peptides Or Proteins (AREA)
- General Preparation And Processing Of Foods (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL119989 | 1997-01-10 | ||
| IL11998997A IL119989A0 (en) | 1997-01-10 | 1997-01-10 | Pharmaceutical compositions for oral treatment of multiple sclerosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1249690A CN1249690A (zh) | 2000-04-05 |
| CN100528222C true CN100528222C (zh) | 2009-08-19 |
Family
ID=11069682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB988031221A Expired - Lifetime CN100528222C (zh) | 1997-01-10 | 1998-01-12 | 共聚物-1在制备治疗多发性硬化症的口服固体药物中的用途 |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0975351B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4216342B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20000070058A (cg-RX-API-DMAC7.html) |
| CN (1) | CN100528222C (cg-RX-API-DMAC7.html) |
| AT (1) | ATE356608T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU737287B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI9807076B8 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2277365C (cg-RX-API-DMAC7.html) |
| CZ (1) | CZ297983B6 (cg-RX-API-DMAC7.html) |
| DE (1) | DE69837324T2 (cg-RX-API-DMAC7.html) |
| EA (1) | EA003128B1 (cg-RX-API-DMAC7.html) |
| HU (1) | HU226612B1 (cg-RX-API-DMAC7.html) |
| IL (2) | IL119989A0 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ336690A (cg-RX-API-DMAC7.html) |
| PL (1) | PL193300B1 (cg-RX-API-DMAC7.html) |
| SK (1) | SK284029B6 (cg-RX-API-DMAC7.html) |
| WO (1) | WO1998030227A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA98214B (cg-RX-API-DMAC7.html) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003521448A (ja) * | 1998-07-23 | 2003-07-15 | ザ・プレジデント・アンド・フェローズ・オブ・ハーバード・カレッジ | 合成ペプチドおよび自己免疫疾患治療のための使用方法 |
| EP1098902A4 (en) | 1998-07-23 | 2002-07-24 | Yeda Res & Dev | TREATMENT OF AUTOIMMUNE DISEASES WITH COPOLYMER 1 AND RELATED COPOLYMERS AND PEPTIDES |
| ES2527760T3 (es) | 1998-07-23 | 2015-01-29 | Yeda Research And Development Co., Ltd. | Tratamiento de enfermedad de Crohn con copolímero 1 y polipéptidos |
| US6800287B2 (en) | 1998-09-25 | 2004-10-05 | Yeda Research And Development Co., Ltd. | Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| US6872739B1 (en) * | 1999-06-04 | 2005-03-29 | Vereniging Voor Christelijk Wetenshappelikjk Onderwijs | Use of riluzole for the treatment of multiple sclerosis |
| CA2375874A1 (en) * | 1999-06-04 | 2000-12-14 | Chris Polman | Use of riluzole for the treatment of multiple sclerosis |
| MXPA02008023A (es) * | 2000-02-18 | 2005-06-30 | Yeda Res & Dev | Formulaciones de copolimero 1 para dosificacion oral, nasal y pulmonar. |
| US7022663B2 (en) | 2000-02-18 | 2006-04-04 | Yeda Research And Development Co., Ltd. | Oral, nasal and pulmonary dosage formulations of copolymer 1 |
| US20020077278A1 (en) | 2000-06-05 | 2002-06-20 | Yong V. Wee | Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders |
| CA2411536A1 (en) * | 2000-06-05 | 2001-12-13 | V. Wee Yong | The use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders |
| WO2002076503A1 (en) | 2000-06-20 | 2002-10-03 | Mayo Foundation For Medical Education And Research | Treatment of central nervous system diseases by antibodies against glatiramer acetate |
| EP1459065B1 (en) | 2001-12-04 | 2010-07-28 | Teva Pharmaceutical Industries, Ltd. | Processes for the measurement of the potency of glatiramer acetate |
| KR20040105740A (ko) | 2002-02-25 | 2004-12-16 | 엘란 파마슈티칼스, 인크. | 염증 치료제의 투여 방법 |
| JP2007521249A (ja) * | 2003-01-24 | 2007-08-02 | エラン ファーマシューティカルズ,インコーポレイテッド | 脱髄疾患および麻痺のための組成物ならびに再有髄化剤を投与することによるそれらの治療 |
| HRP20160455T1 (hr) | 2004-09-09 | 2016-07-15 | Yeda Research And Development Co., Ltd. | Smjese polipeptida, sastavi koji ih sadrže i postupci za njihovu pripremu, te njihove primjene |
| RS55607B1 (sr) | 2009-08-20 | 2017-06-30 | Yeda Research & Development Company Ltd | Niskofrekventna terapija glatiramer acetatom |
| USRE49251E1 (en) | 2010-01-04 | 2022-10-18 | Mapi Pharma Ltd. | Depot systems comprising glatiramer or pharmacologically acceptable salt thereof |
| US8759302B2 (en) | 2010-03-16 | 2014-06-24 | Teva Pharmaceutical Industries, Ltd. | Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis |
| EA025780B1 (ru) | 2010-10-11 | 2017-01-30 | Тева Фармасьютикал Индастриз Лтд. | Цитокиновые биомаркеры в качестве биомаркеров, прогнозирующих клинический ответ на глатирамер ацетат |
| MX2014004309A (es) | 2011-10-10 | 2015-07-06 | Teva Pharma | Polimorfismos de nucleotidos individuales utiles para predecir una respuesta clinica para el acetato de glatiramer. |
| WO2014058976A2 (en) | 2012-10-10 | 2014-04-17 | Teva Pharmaceutical Industries Ltd. | Biomarkers predictive for clinical response for glatiramer acetate |
| UY35790A (es) | 2013-10-21 | 2015-05-29 | Teva Pharma | Marcadores genéticos que predicen la respuesta al acetato de glatiramer |
| CN105884866B (zh) * | 2015-01-26 | 2021-04-20 | 漳州未名博欣生物医药有限公司 | 格拉替雷的化学合成方法 |
| US9155775B1 (en) | 2015-01-28 | 2015-10-13 | Teva Pharmaceutical Industries, Ltd. | Process for manufacturing glatiramer acetate product |
| CN112649537B (zh) * | 2015-04-28 | 2024-03-29 | 深圳翰宇药业股份有限公司 | 多肽混合物高效液相色谱分析方法 |
| US12097292B2 (en) | 2016-08-28 | 2024-09-24 | Mapi Pharma Ltd. | Process for preparing microparticles containing glatiramer acetate |
| AU2017319728B2 (en) | 2016-08-31 | 2024-09-05 | Mapi Pharma Ltd | Depot systems comprising glatiramer acetate |
| IL316573A (en) | 2017-03-26 | 2024-12-01 | Mapi Pharma Ltd | Storage systems containing glatiramer acetate for the treatment of multiple sclerosis |
| US10323289B2 (en) | 2017-06-26 | 2019-06-18 | Institut Pasteur | Treatments to eliminate HIV reservoirs and reduce viral load |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL113812A (en) * | 1994-05-24 | 2000-06-29 | Yeda Res & Dev | Copolymer-1 pharmaceutical compositions containing it and its use |
| US5719296A (en) * | 1995-10-30 | 1998-02-17 | Merck & Co., Inc. | Pseudopeptide lactam inhibitors of peptide binding to MHC class II proteins |
-
1997
- 1997-01-10 IL IL11998997A patent/IL119989A0/xx unknown
-
1998
- 1998-01-12 CN CNB988031221A patent/CN100528222C/zh not_active Expired - Lifetime
- 1998-01-12 KR KR1019997006278A patent/KR20000070058A/ko not_active Ceased
- 1998-01-12 BR BRPI9807076A patent/BRPI9807076B8/pt not_active IP Right Cessation
- 1998-01-12 HU HU0001917A patent/HU226612B1/hu unknown
- 1998-01-12 SK SK931-99A patent/SK284029B6/sk not_active IP Right Cessation
- 1998-01-12 PL PL334566A patent/PL193300B1/pl unknown
- 1998-01-12 WO PCT/US1998/000375 patent/WO1998030227A1/en not_active Ceased
- 1998-01-12 CZ CZ0243799A patent/CZ297983B6/cs not_active IP Right Cessation
- 1998-01-12 CA CA2277365A patent/CA2277365C/en not_active Expired - Lifetime
- 1998-01-12 NZ NZ336690A patent/NZ336690A/en not_active IP Right Cessation
- 1998-01-12 ZA ZA9800214A patent/ZA98214B/xx unknown
- 1998-01-12 JP JP53110898A patent/JP4216342B2/ja not_active Expired - Lifetime
- 1998-01-12 EP EP98901745A patent/EP0975351B1/en not_active Expired - Lifetime
- 1998-01-12 AT AT98901745T patent/ATE356608T1/de not_active IP Right Cessation
- 1998-01-12 DE DE69837324T patent/DE69837324T2/de not_active Expired - Lifetime
- 1998-01-12 EA EA199900621A patent/EA003128B1/ru not_active IP Right Cessation
- 1998-01-12 AU AU58195/98A patent/AU737287B2/en not_active Expired
-
1999
- 1999-07-06 IL IL130820A patent/IL130820A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0975351A4 (en) | 2002-05-15 |
| EP0975351A1 (en) | 2000-02-02 |
| PL193300B1 (pl) | 2007-01-31 |
| PL334566A1 (en) | 2000-03-13 |
| BR9807076B1 (pt) | 2013-10-29 |
| WO1998030227A1 (en) | 1998-07-16 |
| HUP0001917A2 (hu) | 2000-10-28 |
| CN1249690A (zh) | 2000-04-05 |
| CA2277365C (en) | 2011-04-12 |
| EA199900621A1 (ru) | 2000-02-28 |
| IL119989A0 (en) | 1997-04-15 |
| CZ297983B6 (cs) | 2007-05-16 |
| ATE356608T1 (de) | 2007-04-15 |
| AU5819598A (en) | 1998-08-03 |
| SK93199A3 (en) | 2000-11-07 |
| JP4216342B2 (ja) | 2009-01-28 |
| EP0975351B1 (en) | 2007-03-14 |
| IL130820A (en) | 2007-03-08 |
| SK284029B6 (sk) | 2004-08-03 |
| KR20000070058A (ko) | 2000-11-25 |
| HUP0001917A3 (en) | 2001-12-28 |
| CA2277365A1 (en) | 1998-07-16 |
| HK1025737A1 (en) | 2000-11-24 |
| BR9807076A (pt) | 2000-05-02 |
| BRPI9807076B8 (pt) | 2021-05-25 |
| HU226612B1 (en) | 2009-04-28 |
| DE69837324T2 (de) | 2007-11-29 |
| DE69837324D1 (de) | 2007-04-26 |
| NZ336690A (en) | 2001-05-25 |
| AU737287B2 (en) | 2001-08-16 |
| ZA98214B (en) | 1999-08-11 |
| CZ243799A3 (cs) | 2000-06-14 |
| JP2001511121A (ja) | 2001-08-07 |
| EA003128B1 (ru) | 2003-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6214791B1 (en) | Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1 | |
| JP4216342B2 (ja) | コポリマー1の摂取又は吸入を通じての多発性硬化症の治療 | |
| WO1998030227A9 (en) | Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1 | |
| AU742970B2 (en) | Method of suppressing beta-amyloid-related changes in Alzheimer's disease | |
| KR100239743B1 (ko) | 인슐린을 함유하는 타입 1 당뇨병 치료용 경구투여, 장내투여 또는 흡입경구투여용 제제 | |
| JP3712260B2 (ja) | 自己免疫疾患のバイスタンダー抑制 | |
| KR0159046B1 (ko) | 포유류의 자기면역 포도막망막염의 치료 또는 예방방법 | |
| JP2002503658A (ja) | COP−1及びTh−2促進性サイトカインを使用した、多発性硬化症の治療 | |
| JP3183378B2 (ja) | ムチン産生促進剤 | |
| HK1025737B (en) | Treatment of multiple sclerosis through ingestion of copolymer-1 | |
| MXPA99006457A (en) | Treatment of multiple sclerosisthrough ingestion or inhalation of copolymer-1 | |
| AU781126B2 (en) | Method of suppressing beta-amyloid-related changes in Alzheimer's disease | |
| WO2025160184A1 (en) | Methods for the prophylaxis and treatment of obesity and related conditions and disorders | |
| CN118121583A (zh) | 赖氨酸在制备治疗多发性硬化症药物中的应用 | |
| CN1353616A (zh) | 一种物质在pns中的新用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| C10 | Entry into substantive examination | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CX01 | Expiry of patent term |
Granted publication date: 20090819 |
|
| CX01 | Expiry of patent term |